Dexmedetomidine No Better Than Propofol for Adults With Sepsis
For light sedation of mechanically ventilated patients with sepsis, number of days alive without delirium or coma similar between groups
Anesthetics
FDA Approves Posimir for Postsurgical Analgesia
Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site.
Byfavo Now Available for Induction, Maintenance of Procedural Sedation
Byfavo, a Schedule IV controlled substance, is a rapid-acting, reversible benzodiazepine.
Neuromuscular Blocker Recalled Due to Label Mix-Up
The recall was initiated after a product complaint revealed that a portion of the lot contained vials mislabeled as Phenylephrine Hydrochloride Injection 100mg/10mL.
New Drugs Approved in 2020
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
Recall: Lidocaine Identified in Dexmedetomidine Vials
Administration of the recalled product to a patient with lidocaine allergy could potentially result in anaphylaxis if trace amounts of lidocaine are present.
Type of Anesthesia Not Linked to Dementia Risk in Older Adults
Dementia risk did not differ by general, regional anesthesia in seniors undergoing elective surgery.
CNS-Active Meds Often Prescribed for Older Adults With Dementia
Overall, Rx filled for antidepressants in 49.8 percent, opioids in 29.8 percent, anxiolytics in 26.8 percent
FDA: Drug “In-Use Time” May Be Extended in Certain Cases
has provided guidance to healthcare facilities and providers looking to use certain drugs beyond their labeled “in-use times” due to supply issues related to the coronavirus disease 2019 (COVID-19) pandemic.
Fresenius Kabi Recalls Dexmedetomidine Over Possible Lidocaine Cross-Contamination
Fresenius Kabi announced the voluntary recall of 2 lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200mcg/50mL, 50mL fill in a 50mL vial due to the possibility of cross-contamination with lidocaine.
